Anacor Pharmaceuticals, Inc. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8d0411a3-d0ce-4274-9350-bd2eec59927a/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2015 | $82.4M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010583 |
| FY 2014 | $20.7M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-002293 |
| FY 2013 | $17.2M | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-002522 |
| FY 2012 | $10.7M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-002983 |
| FY 2011 | $20.3M | 2011-01-01 – 2011-12-31 | evidence 0001047469-13-002983 |
| FY 2010 | $27.8M | 2010-01-01 – 2010-12-31 | evidence 0001047469-13-002983 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).